Rivellese, Felice http://orcid.org/0000-0002-6759-7521
Surace, Anna E. A. http://orcid.org/0000-0001-9589-3005
Goldmann, Katriona
Sciacca, Elisabetta http://orcid.org/0000-0001-7525-1558
Çubuk, Cankut http://orcid.org/0000-0003-4646-0849
Giorli, Giovanni
John, Christopher R.
Nerviani, Alessandra http://orcid.org/0000-0003-4064-4014
Fossati-Jimack, Liliane http://orcid.org/0000-0003-3757-3999
Thorborn, Georgina
Ahmed, Manzoor
Prediletto, Edoardo http://orcid.org/0000-0001-6830-0614
Church, Sarah E. http://orcid.org/0000-0002-7194-4282
Hudson, Briana M.
Warren, Sarah E.
McKeigue, Paul M.
Humby, Frances http://orcid.org/0000-0003-1280-9133
Bombardieri, Michele
Barnes, Michael R. http://orcid.org/0000-0001-9097-7381
Lewis, Myles J. http://orcid.org/0000-0001-9365-5345
Pitzalis, Costantino http://orcid.org/0000-0003-1326-5051
Rivellese, Felice
Giorli, Giovanni
Nerviani, Alessandra
Fossati-Jimack, Liliane
Thorborn, Georgina
Humby, Frances
Bombardieri, Michele
Lewis, Myles J.
Durez, Patrick
Buch, Maya H.
Rizvi, Hasan
Mahto, Arti
Montecucco, Carlomaurizio
Lauwerys, Bernard
Ng, Nora
Ho, Pauline
Romão, Vasco C.
da Fonseca, João Eurico Cabral
Verschueren, Patrick
Kelly, Stephen
Sainaghi, Pier Paolo
Gendi, Nagui
Dasgupta, Bhaskar
Cauli, Alberto
Reynolds, Piero
Cañete, Juan D.
Ramirez, Julio
Celis, Raquel
Moots, Robert
Taylor, Peter C.
Edwards, Chris J.
Isaacs, John
Sasieni, Peter
Choy, Ernest
Thompson, Charlotte
Bugatti, Serena
Bellan, Mattia
Congia, Mattia
Holroyd, Christopher
Pratt, Arthur
White, Laura
Warren, Louise
Peel, Joanna
Hands, Rebecca
Hadfield, Gaye
Pitzalis, Costantino
,
Funding for this research was provided by:
DH | NIHR | Efficacy and Mechanism Evaluation Programme (11/100/76)
Versus Arthritis Experimental Arthritis Treatment Centre
DH | National Institute for Health Research (TRF-2018-11-ST2-002)
Versus Arthritis clinical lectureship (grant number: 21890).
Article History
Received: 28 April 2021
Accepted: 21 March 2022
First Online: 19 May 2022
Competing interests
: S.E.C., B.M.H. and S.E.W. are employees and stockholders of NanoString Technologies, Inc. C.P. and M.J.L. are inventors on a patent application (no. GB 2100821.4), submitted by Queen Mary University of London, that covers methods used to select treatments in RA. All other authors declare no competing interests.